• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)

$1,995.00 – $3,990.00

Clear
SKU: KLI6490034 Category: Biotechnology Market Research Pages: 150
  • Description
  • Table of Contents
  • Latest reports

Description

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells.

For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the pharmaceutical market. New scientific developments and recent changes in the U.S. Federal government’s policy towards stem cells have made this potential more relevant. Kalorama Information has tackled the question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development. Kalorama analyst Alison Sahoo has built models to determine the best, moderate and worst case scenarios for the three key markets for stem cells:

  • Stem Cells in Drug Development
  • Stem Cells in Cord Blood Banking
  • Stem Cell Therapeutics

The potential of stem cell therapeutics is provided, broken down by disease:

  • Cardiovascular disease
  • Lung disease
  • Tooth disease
  • Arthritis
  • Wrinkles/aging skin
  • Incontinence
  • Osteoporosis
  • Diabetes
  • Cancer
  • Bladder disease
  • Infertility
  • Orthopedics
  • Alzheimer’s disease
  • Burns (severe)
  • Lupus
  • Parkinson’s disease
  • Liver failure
  • Multiple sclerosis
  • Critical limb ischemia
  • Intestinal disease
  • Sickle cell disease
  • Multiple myeloma
  • NH Lymphoma
  • Leukemia

The following trends are discussed in this report:

  • Ethical Questions
  • U.S. – State and Federal Initiatives
  • Research Funding
  • Cord Blood Initiatives
  • International Initiatives
  • Stem Cell Patents
  • Other Healthcare Regulations

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

For Kalorama’s take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information’s Key Point Blog at
http://kaloramakeypoint.blogspot.com/

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Scope and Methodolgy
  • Introduction
  • Current Stem Cell Therapies
  • Developmental Stem Cell Therapies
  • Issues In Stem Cell Research
  • Stem Cell Forecasts

CHAPTER TWO: INTRODUCTION

  • The Promise of Stem Cells In Medical Treatment
  • Types of Stem Cells
    • Embryonic Stem Cells
    • Adult Stem Cells
    • Cord Blood Stem Cells
  • Stem Cell Harvesting
  • Embryonic Stem Cells
  • Therapeutic Cloning
  • Unfertilized Eggs
  • Adult Stem Cells
  • Leukapheresis
  • Peripheral Blood
  • Cord Blood Stem Cells
  • Transplantation Approaches
    • Autologous Transplantation
    • Allogenic Transplantation
    • Transplantation Procedures
  • Cancerous Stem Cells
  • Other Harmful Stem Cells
  • Stem Cells in Drug Development
  • Stem Cell Therapeutics
  • Stem Cells Targeting Drugs
  • Stem Cell Generated Organs

CHAPTER THREE: CURRENT STEM CELL THERAPIES

  • Cancer
  • Leukemia
  • Gene Therapy
  • Multiple Myeloma
  • Non-Hodgkin’s Lymphoma
  • Non Cancerous Diseases
  • Aplastic anemia
  • Immunodeficiency
  • Lupus
  • Sickle Cell Disease
  • Other Conditions

CHAPTER FOUR: DEVELOPMENTAL STEM CELL THERAPIES

  • Alzheimer’s Disease
  • Arthritis
  • Bladder Disease
  • Burns
  • Cancer
  • Cardiovascular Conditions
  • Critical Limb Ischemia
  • Diabestes
  • Esophagal Disease
  • Incontinence
  • Infertility
  • Intestinal Disease
  • Liver Failure
  • Lung Disease
  • Multiple Sclerosis
  • Orthopedics
  • Osteoporosis
  • Parkinson’s Disease
  • Sickle Cell Disease
  • Tooth Disease
  • Wrinkles/Aging Skin

CHAPTER FIVE: STEM CELL FORECASTS

  • Best Case
    • Stem Cell Therapeutics
    • Umbilical Cord Blood Banking
    • Fees Related to Drug Development
  • Most Likely Case
    • Stem Cell Therapeutics
    • Umbilical Cord Blood Banking
    • Fees Related to Drug Development
  • Worst Case
    • Stem Cell Therapeutics
    • Umbilical Cord Blood Banking
    • Fees Related to Drug Development

CHAPTER SIX: ISSUES IN STEM CELL RESEARCH

  • Ethical Questions
  • U.S. – State and Federal Initiatives
    • Research Funding
    • Federal Funding
    • State Funding
    • Cord Blood Initiatives
    • International Initiatives
  • Stem Cell Patents
  • Other Healthcare Regulations

LIST OF EXHIBITS CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1 Total Market for Stem Cell Technologies in $ Millions, 2010 – 2020
  • Table 1-2 Stem Cell Therapeutics Market in $ Millions, 2010 – 2020
  • Table 1-3 Total Market for Cord Blood Banking Fees in $ Millions, 2010 – 2020
  • Table 1-4 Total Market for Stem Cell Drug Development Technologies in $ Millions, 2010 – 2020
  • Figure 1-1 Total Market for Stem Cells – Most Likely Case in $ Millions, 2010 – 2020

CHAPTER TWO: INTRODUCTION

  • Table 2-1 Established and Emerging Artificial Organ Products by Market Segment, 2010

CHAPTER THREE: CURRENT STEM CELL THERAPIES

  • Table 3-1 Types of Leukemia, 2011

CHAPTER FOUR: DEVELOPMENTAL STEM CELL THERAPIES

  • Table 4-1 Global Disease Populations Addressed by Potential Stem Cell Therapies, 2011
  • Table 4-2 Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2010 and 2020
  • Table 4-3 Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2010 and 2020
  • Table 4-4 Features and Types of Urinary Incontinence, 2011
  • Table 4-5 Types and Causes of Male Infertility, 2011
  • Table 4-6 Common Diseases of the Lungs, 2011

CHAPTER FIVE: STEM CELL FORECASTS

  • Table 5-1 Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2011
  • Table 5-2 Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2010 – 2020
  • Table 5-3 Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2010 – 2020
  • Table 5-4 131 Best Case: Cord Blood Banking Revenues in $ Millions, 2007 – 2020
  • Table 5-5 Best Case: Stem Cell-Based Drug Development Technology Fees, 2010 – 2020
  • Table 5-6 Best Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2010 – 2020
  • Table 5-7 Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2010 – 2020
  • Table 5-8 Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2010 – 2020
  • Table 5-9 Most Likely Case: Cord Blood Banking Revenues in $ Millions, 2010 – 2020
  • Table 5-10 Most Likely Case: Stem Cell-Based Drug Development Technology Fees in Millions, 2010 – 2020
  • Table 5-11 Most Likely Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2010 – 2020
  • Table 5-12 Worst Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2010 – 2020
  • Table 5-13 Worst Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2010 – 2020
  • Table 5-14 Worst Case: Cord Blood Banking Revenues in $ Millions, 2010-2020
  • Table 5-15 Worst Case: Stem Cell-Based Drug Development Technology Fees in Millions, 2010-2020
  • Table 5-16 Worst Case: Stem Cell-Based Drug Development Technology Fees in $ Millions 2010-2020

CHAPTER SIX: ISSUES IN STEM CELL RESEARCH

  • Table 6-1 NIH Funding for Stem Cell Research, 2002 – 2010 in $ Million
  • Table 6-2 U.S. State Embryonic & Fetal Research Laws
  • Table 6-3 Positions on Human ES Cell Research by Country, 2011
  • Table 6-4 EU Laws on hESC Research by Country

 

    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024
    September 11, 2024
    Worldwide Sequencer Market, 2023-2028
    August 8, 2024
    The Worldwide Market for Liquid Biopsy, 6th Edition
    December 29, 2023
    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023

Related products

  • Placeholder image

    Immunomodulators in Cancer Therapy: Emerging Products and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Glycosylated Protein Therapeutics – A Market Briefing

    $795.00 – $1,590.00
  • Placeholder image

    U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed.

    $3,500.00 – $7,000.00
  • Placeholder image

    Stem Cell Therapeutics Markets

    $995.00 – $5,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
US Pharmaceutical, Medical Device, Diagnostics MarketsVaccine Production (Trends, Techniques, Key Players, Spending Estimates and...
Scroll to top